An important protein of the Ras‐signalling pathway identified within these clusters was the receptor tyrosine kinase IGF1R, for which several drugs already exist, but are not used in the context of NRAS‐mutant melanoma to the best of our knowledge. This evidence concerns the gene NRAS and melanoma.